Decision making is not always easy, especially under complex circumstances. Deciding which vaccines—or which of any sort of health care products or services—that one should invest in requires a ...

Throughout most of the history of vaccines, severe infectious diseases were so common and the benefits of vaccination were so obvious that decisions regarding the development and use of vaccines ...

On June 18, 2025, FDA announced for public comment a Post-market Assessment Prioritization Tool (Prioritization Tool) as an enhanced systematic process for post-market scientific assessment of ...